Cannabics Pharmaceuticals IncCannabics Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you work at Cannabics Pharmaceuticals Inc and you wish to licence your ESG aseessment, please contact us. This page displays a free Environmental, Social and Governance analysis for Cannabics Pharmaceuticals Inc. The dashboard includes a Q&A section on Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 2.7, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Cannabics Pharmaceuticals Inc 
Low
0 - 3

6.2

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Cannabics Pharmaceuticals Inc 
2.7

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
563ReproCell Inc
6.3
High
563Venus Remedies Ltd
6.3
High
586Cannabics Pharmaceuticals Inc
6.2
High
586Althea Group Holdings Ltd
6.2
High
586AlzeCure Pharma AB
6.2
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Cannabics Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Cannabics Pharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Cannabics Pharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Cannabics Pharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Cannabics Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Cannabics Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Cannabics Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids for the treatment of cancer anorexia-cachexia syndrome; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.

Sorry!

Failed to process!